Optimal timing for adjuvant radiation therapy in breast cancer: A comprehensive review and perspectives
- 31 August 2009
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 71 (2), 102-116
- https://doi.org/10.1016/j.critrevonc.2008.09.002
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric studyAnnals Of Oncology, 2008
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Interaction Between Estrogen Receptor Alpha, Ionizing Radiation and (anti-) Estrogens in Breast Cancer CellsBreast Cancer Research and Treatment, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Hormonoradiothérapie adjuvante concomitante des cancers du sein : état de l'artCancer/Radiothérapie, 2004
- Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgeryBritish Journal of Cancer, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast CancerNew England Journal of Medicine, 1996
- Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute TrialsWorld Journal of Surgery, 1994